StreetAlpha.app
Home › Stocks › MMED

MiniMed Group, Inc. (MMED)

Healthcare
$16.01
▼ −1.54%
LAST CLOSE · NOV 20

MiniMed makes insulin pumps, smart insulin pens, and glucose sensors for people with diabetes. It last closed at $16.01 on Nov 20, down 1.54% on the day. The next earnings report for MMED is expected around Tue, Dec 1, 2026. For the quarter ended Jul 2026, MMED reported EPS of $0.00 on revenue of $843.0M, with revenue up 16.6% from a year ago.

AI Auto Pilots
Is MMED in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MMED.

Key Stats

Last 12 months
Results
Revenue
$3.2B
Net income
−$314.0M
−9.7% margin
EPS (diluted)
−$1.22
Free cash flow
−$316.0M
−9.8% margin
Valuation
Market cap
$4.5B
281.3M shares
P/E
–
No P/E while losing money
Price to sales
1.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$207.0M
At Jul 31
Shareholder equity
$3.6B
Shares outstanding
281.3M
At Sep 3
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2024: $2.5B$2.5BFY2024FY2025: $2.7B$2.7BFY2025FY2026: $3.1B$3.1BFY2026

From MMED's SEC filings, latest 10-Q for the period ending Jul 31, 2026 (filed Sep 8). Last 12 months adds up the four latest quarters.

Next report
Dec 1
Estimated date · Time not announced
Reported EPS
$0.00
Quarter ended Jul 2026
Year ago EPS
-$0.08
Same quarter last year
Revenue
$843.0M
+16.6% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Jan 2025: -$0.04Jan '25Apr 2025: -$0.68Apr '25Jul 2025: -$0.08Jul '25Jan 2026: -$0.47Jan '26Apr 2026: -$0.71Apr '26Jul 2026: $0.00Jul '26Latest $0.00
Revenue by quarter
Jan 2025: $687.0MJan '25Apr 2025: $724.0MApr '25Jul 2025: $723.0MJul '25Jan 2026: $790.0MJan '26Apr 2026: $837.0MApr '26Jul 2026: $843.0MJul '26Latest $843.0M
How MMED moved after its last 2 reports
Average move the session after a report ±13.3%
Sep 1, 2026Time not announced+10.7%
Jun 3, 2026Time not announced+15.9%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on MMEDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on MMED
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on MMED

Technical Analysis

MMED · as of the Nov 20 close · updated each morning
Falling, nearing oversold

The stock is 13% below its 20 day and 19% below its 50 day average. Momentum is weak (RSI 37), near oversold. The nearest support is the swing low (Jul 23) at $15.96, and the nearest resistance the Pivot at $16.24.

Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityNormal, 6.1%/day
Key levels
$24.4352 week high+52.6%
$19.0350 day average+18.9%
$18.93100 day average+18.2%
$18.0620 day average+12.8%
$17.51Swing high (Jul 21)+9.4%
$16.56Pivot R1+3.4%
$16.24Pivot+1.4%
$16.01Last close
$15.96Swing low (Jul 23)−0.3%
$15.69Pivot S1−2.0%
$10.6552 week low−33.5%
Indicators
RSI (14)36.63Weak, oversold below 30Neutral
MACD-0.59Below its signal lineBearish
Stochastic5.3Near the bottom of its rangeOversold
ADX (14)24.1Weak trend
Williams %R-97.8Oversold below −80, overbought above −20Oversold
CCI (20)-179.6Oversold below −100, overbought above 100Oversold
Rate of change−4.2%Change over 10 sessionsBearish
ATR (14)$0.98Typical daily range, 6.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for MMED

What happened before

See how MMED did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for MMEDHow many large options trades hit MMED, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

MMED Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲114 buying vs 34 selling
  • ▲Held by funds +7.5 pts
  • ▲Funds holding +51
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding14998+52.0%
In funds' top 1030–
Held by funds20.7%13.2%+7.5 pts
New / increased68 / 4653 / 21+54.1%
Reduced / sold out16 / 1813 / 13+30.8%
Put/call ratio1.06––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See MMED institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MMED is in one of them and how their past MMED trades turned out.

MMED in the AI portfolios
Loading…

MMED News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered MMED in an article yet. Here's the latest on the wider market.

MMED in the news

About MiniMed Group

MiniMed is a medical technology company based in Northridge, California, that develops, manufactures, and sells products for managing diabetes. Its main offerings include automated insulin delivery systems that pair an insulin pump with a glucose sensor and dosing software, along with smart insulin pens and continuous glucose monitoring sensors. Its customers are people with diabetes who need intensive insulin therapy, along with their caregivers and healthcare providers. The company also sells consumable supplies, software, and related services.

Headquarters
Northridge, CA